miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy

Figure 3

Graph showing the mean copy number of miR-31-5p in the patient group—treated and untreated with IgIV—and in the control group.